US approves first new Alzheimer’s drug in 20 years

There has been controversy around aducanumab, which targets the cause rather than the symptoms.

Share this:

What do you think?

Written by Headlines

Mainstream media is often "Fake News." Nevertheless, one needs to see what others are seeing and then read with discernment.

Leave a Reply

Your email address will not be published. Required fields are marked *

Britain names seasoned diplomat as new consul general in Hong Kong

Country Music Television Urges Viewers to ‘Wear Orange’ for Bloomberg-Backed Gun Control Campaign